Science News
from research organizations

Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia

Date:
February 21, 2017
Source:
SUNY Downstate Medical Center
Summary:
Researchers recently discovered that an inhibitory brain receptor triggers synaptic pruning in adolescence. Drugs that selectively target these receptors, when administered during adolescence, can alter synapse number, with possible implications for the treatment of autism and schizophrenia.
Share:
FULL STORY

Memories are formed at structures in the brain known as dendritic spines, which communicate with other brain cells through "synapses." The number of these brain connections decreases by half after puberty in a process termed adolescent "synaptic pruning" that is necessary for normal learning in adulthood. However, the pruning away of unnecessary synapses does not follow the normal process in diseases such as autism and schizophrenia, where the abnormality is thought to underlie many of the cognitive impairments associated with these disorders.

Researchers at SUNY Downstate Medical Center recently discovered that an inhibitory brain receptor triggers pruning in adolescence in a pre-clinical model. Now, a new article by the SUNY Downstate researchers shows that drugs that selectively target these receptors, when administered during adolescence, can alter synapse number.

Sheryl S. Smith, PhD, professor of physiology and pharmacology at Downstate, explains, "Drugs that enhance activity of this inhibitory receptor reduce synapse number, while drugs that decrease this inhibitory receptor increase synapse number."

Dr. Smith adds, "These findings suggest that targeted drug therapies during adolescence could potentially be used to normalize synapse number in the brains of individuals with abnormal numbers of synapses, such as found in autism and schizophrenia." Dr. Smith cautions, however, that at this time such drugs are not yet available for use in humans.


Story Source:

Materials provided by SUNY Downstate Medical Center. Note: Content may be edited for style and length.


Journal Reference:

  1. Sonia Afroz, Hui Shen, Sheryl S. Smith. α4βδ GABAA receptors reduce dendritic spine density in CA1 hippocampus and impair relearning ability of adolescent female mice: Effects of a GABA agonist and a stress steroid. Neuroscience, 2017; DOI: 10.1016/j.neuroscience.2017.01.051

Cite This Page:

SUNY Downstate Medical Center. "Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia." ScienceDaily. ScienceDaily, 21 February 2017. <www.sciencedaily.com/releases/2017/02/170221152242.htm>.
SUNY Downstate Medical Center. (2017, February 21). Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia. ScienceDaily. Retrieved May 29, 2017 from www.sciencedaily.com/releases/2017/02/170221152242.htm
SUNY Downstate Medical Center. "Drugs that alter inhibitory targets offer therapeutic strategies for autism, schizophrenia." ScienceDaily. www.sciencedaily.com/releases/2017/02/170221152242.htm (accessed May 29, 2017).

RELATED STORIES